$Zevra Therapeutics (ZVRA.US)$ NEWS Zevra Therapeutics Refin...
NEWS
Zevra Therapeutics Refinances Existing Debt with up to $100M in Committed Capital under New Credit Facility
Zevra Therapeutics, Inc. secures a new $100M credit facility led by Perceptive Advisors and Healthcare Royalty to support its rare disease therapeutics development. The facility includes an initial draw of $60M, with additional tranches available upon meeting certain conditions. Zevra retires existing debt of $43.1M, with net proceeds of $14.0M. The five-year facility bears interest at 12.33% per annum and allows in-kind interest payments. This move aims to strengthen Zevra's financial position and advance its strategic goals for 2024 and beyond.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment